53
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      An Immune Basis for Malaria Protection by the Sickle Cell Trait

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Malaria resistance by the sickle cell trait (genotype HbAS) has served as the prime example of genetic selection for over half a century. Nevertheless, the mechanism of this resistance remains the subject of considerable debate. While it probably involves innate factors such as the reduced ability of Plasmodium falciparum parasites to grow and multiply in HbAS erythrocytes, recent observations suggest that it might also involve the accelerated acquisition of malaria-specific immunity.

          Methods and Findings

          We studied the age-specific protection afforded by HbAS against clinical malaria in children living on the coast of Kenya. We found that protection increased with age from only 20% in the first 2 y of life to a maximum of 56% by the age of 10 y, returning thereafter to 30% in participants greater than 10 y old.

          Conclusions

          Our observations suggest that malaria protection by HbAS involves the enhancement of not only innate but also of acquired immunity to the parasite. A better understanding of the underlying mechanisms might yield important insights into both these processes.

          Abstract

          In a Kenyan population, protection against malaria by sickle cell trait increased over the first 10 years of life, suggesting that the mechanism of protection involves acquired immunity to the parasite.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Common west African HLA antigens are associated with protection from severe malaria.

          A large case-control study of malaria in West African children shows that a human leucocyte class I antigen (HLA-Bw53) and an HLA class II haplotype (DRB1*1302-DQB1*0501), common in West Africans but rare in other racial groups, are independently associated with protection from severe malaria. In this population they account for as great a reduction in disease incidence as the sickle-cell haemoglobin variant. These data support the hypothesis that the extraordinary polymorphism of major histocompatibility complex genes has evolved primarily through natural selection by infectious pathogens.
            • Record: found
            • Abstract: found
            • Article: not found

            Protective effects of the sickle cell gene against malaria morbidity and mortality.

            The high frequency of the sickle-cell haemoglobin (HbS) gene in malaria endemic regions is believed to be due to a heterozygote (HbAS) advantage against fatal malaria. Data to prospectively confirm the protection associated with HbAS against mortality are lacking. We show that HbAS provides significant protection against all-cause mortality, severe malarial anaemia, and high-density parasitaemia. This significant reduction in mortality was detected between the ages of 2 and 16 months, the highest risk period for severe malarial anaemia in this area. These data are important in understanding the role of malaria in the selection and maintenance of the sickle cell gene.
              • Record: found
              • Abstract: found
              • Article: not found

              Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.

              Serum antibodies from 1071 people in two Kenyan villages were assayed using eight different recombinant Apical Membrane Antigen 1 (AMA1) protein constructs to investigate their role in naturally acquired immunity. In both communities, antibodies against the full-length ectodomain (both FVO and 3D7 allele constructs) prior to a malaria transmission season were significantly associated with protection from malaria in the following 6 months, even after adjusting for age and antibody reactivity to whole parasite (schizont) extract. However, these protective associations of antibodies were only seen among subjects that were parasite slide positive at the time of pre-season serum sampling. Competition ELISAs with the FVO and 3D7 allele constructs showed that antibodies can recognise either conserved or allele-specific epitopes in AMA1. Results encourage the development of an AMA1 vaccine based on the full-length ectodomain, and indicate that the function of human antibodies to allele-specific and conserved epitopes in AMA1 should be studied further.

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                pmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                May 2005
                31 May 2005
                : 2
                : 5
                : e128
                Affiliations
                [1] 1Kenya Medical Research Institute/Wellcome Trust Programme, Centre for Geographic Medicine Research Coast, Kilifi District Hospital, KilifiKenya
                [2] 2Nuffield Department of Medicine, John Radcliffe Hospital OxfordUnited Kingdom
                [3] 3Department of Paediatrics, John Radcliffe Hospital OxfordUnited Kingdom
                [4] 4Blood Research Laboratory, National Blood Service—Oxford John Radcliffe Hospital, OxfordUnited Kingdom
                [5] 5Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital OxfordUnited Kingdom
                [6] 6Medical Research Council Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine LondonUnited Kingdom
                [7] 7Weatherall Institute of Molecular Medicine, John Radcliffe Hospital OxfordUnited Kingdom
                University of Rome Italy
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Author Contributions: TNW, TWM, DJR, DJW, and KM designed the study. TNW, NDA, SW, and MK analyzed the data. TNW wrote the paper.

                *To whom correspondence should be addressed. E-mail: twilliams@ 123456kilifi.mimcom.net
                Article
                10.1371/journal.pmed.0020128
                1140945
                15916466
                cc5c655c-d767-476a-8e19-21e3e366d11e
                Copyright: © 2005 Williams et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
                History
                : 23 November 2004
                : 18 March 2005
                Categories
                Research Article
                Infectious Diseases
                Infectious Diseases
                Malaria

                Medicine
                Medicine

                Comments

                Comment on this article

                Related Documents Log